Three-Month Randomized, Controlled, NonInferiority Trial Evaluating the Safety and Efficacy of IOP-Lowering Microdrops Administered with the Nanodropper® Adaptor in Glaucoma Patients

Category Primary study
JournalInvestigative Ophthalmology and Visual Science
Year 2024
This article has no abstract
Epistemonikos ID: 5933eabce22d78b51f6aecb045bc9454bec5f24b
First added on: Feb 19, 2025